首页> 外国专利> METHOD OF INTRAVITREAL DRUG INTRODUCTION DURING EXTRACAPSULAR CATARACT EXTRACTION

METHOD OF INTRAVITREAL DRUG INTRODUCTION DURING EXTRACAPSULAR CATARACT EXTRACTION

机译:皮内注射白内障引出药物的方法。

摘要

FIELD: medicine.;SUBSTANCE: method of intravitreal drug introduction during extracapsular cataract extraction. It involves making a cataract scleral-corneal tunnel incision and two corneocenteses, then anterior capsulorhexis in diameter 4.5-5.5 mm, hydrodissection and hydrodelineation. The lens substance is removed, a circular uninterrupted posterior capsulorhexis in diameter 4.0-5.0 mm is made, a soft intraocular lens is implanted in a capsular sac. The anterior and posterior chambers are filled with a cohesive viscoelastic; intravitreal drug injection is carried out by a syringe and an injection needle introduced in a vitreous body through one of the corneocenteses, and then - openings of the anterior and posterior capsulorhexes followed by entrapment of an optical portion of the intraocular lens in the opening of the posterior capsulorhexis.;EFFECT: method allows maintaining integrity of the ciliary body and anterior chamber breakdown during the injection, as well as developing bleeding, uveitis, ciliochoroidal detachment, proliferative vitreoretinopathy, retinal detachment; it differs by the absence of pain syndrome accompanying carrying out the injection.;1 ex
机译:领域:药物;物质:囊外白内障摘除术中玻璃体内药物引入的方法。它包括制作白内障巩膜-角膜隧道切口和两个角膜穿刺术,然后进行直径为4.5-5.5 mm的前撕囊术,水力解剖和水力勾画。除去晶状体物质,制成直径为4.0-5.0mm的不间断的圆形后囊膜,将软的人工晶状体植入囊囊中。前腔和后腔充满粘性粘弹性。玻璃体内药物注射是通过注射器和注射针通过角膜穿刺术之一引入玻璃体中进行的,然后-撕开前囊膜和后囊膜,然后将人工晶状体的光学部分包裹在囊膜的开口中。效果:该方法可在注射过程中保持睫状体的完整性和前房破裂,并发展为出血,葡萄膜炎,脉络膜脉络膜脱离,增生性玻璃体视网膜病变,视网膜脱离;它的不同之处在于注射时不伴有疼痛综合征。1ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号